DMH1

Catalog No.S7146 Batch:S714605

Print

Technical Data

Formula

C24 H20 N4 O
Molecular Weight 380.44 CAS No. 1206711-16-1
Solubility (25°C)* In vitro DMSO 12 mg/mL (31.54 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description DMH1 is a selective BMP receptor inhibitor with IC50 of 107.9 nM for ALK2, exhibiting no inhibition on AMPK, ALK5, KDR (VEGFR-2) or PDGFR. This compound inhibits autophagy.
Targets
ALK2 [1]
(Cell-free assay)
107.9 nM
In vitro DMH1 inhibits BMP signaling with IC50 of 100 nM, and selectively inhibits the BMP-induced Smad1/5/8 activation. [1] This compound increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells. [3] In addition, as a BMP inhibitor, it significantly reduces NSCLC cell growth, migration and invasion. [4]
In vivo DMH1 dorsalizes the embryonic axis without disrupting the angiogenic process in Zebrafish embryos. [1] In proepicardial explants, this compound results in the greatest inhibition of epithelial sheet migration. [2] This chemical (5 mg/kg i.p.) attenuates xenograft lung tumor growth in mice bearing A549 xenograft. [4]

Protocol (from reference)

Kinase Assay:[1]
  • Kinase assay

    All kinase assays are conducted by Reaction Biology Corp. In brief, this compound is tested at 10 concentrations by 3-fold serial dilutions starting at 30 μM, using nonspecific kinase inhibitor staurosporine as control. In vitro kinase reactions are carried out in the presence of 10 μM (33P)γATP. Five kinases tested are the human BMP type-I receptor activin receptor-like kinase 2 (ALK-2/ACVR1), the human TGFβ type-I receptor activin receptor-like kinase 5 (Alk5/TGFβR1), the human VEGF type-II receptor (KDR/Flk-1/VEGFR2), the human AMP-activated protein kinase (AMPK/A1/B1/G1) and the human platelet-derived growth factor receptor-β (PDGFRβ).
Cell Assay:[4]
  • Cell lines

    A549 cells

  • Concentrations

    ~5 μM

  • Incubation Time

    48-96 hours

  • Method

    About 10,000 A549 cells per well are seeded in 96-well plates and incubated for overnight. The culture medium is then changed to fresh medium containing DMSO or DMH1 at various concentrations. The cells are then incubated for 48 hours and 96 hours before treatment termination by replacing the medium with 100 μL of 10% trichloroacetic acid in 1× PBS, followed by incubation at 4°C for at least 1 hour. Subsequently, the plates are washed with water and air dried. The plates are stained with 50 μL 0.4% sulphorhodamine assay in 1% acetic acid for 30 minutes at room temperature. Unbound dye is washed off with 1% acetic acid. After air drying and solubilization of the protein-bound dye in 10 mM Tris solution, absorbance is read in a microplate reader at 565 nm.
Animal Study:[4]
  • Animal Models

    Mice bearing A549 xenograft.

  • Dosages

    ~5 mg/kg

  • Administration

    i.p.

References

  • https://pubmed.ncbi.nlm.nih.gov/20020776/
  • https://pubmed.ncbi.nlm.nih.gov/21740033/
  • https://pubmed.ncbi.nlm.nih.gov/22848549/
  • https://pubmed.ncbi.nlm.nih.gov/24603907/

Customer Product Validation

The combined treatment with miR-140-5p mimics and some common chemotherapeutics did not have any effect on the SK-MES1 cell line, whereas miR-140-5p and DMH1 and cisplatin decreased the proliferation ofthe A549 cells. Data are presented as mean±SEM of three individual experiments undertaken in triplicate. t-Test was used to assess significance with *p<0.05.

Data from [ , , Anticancer Res, 2017, 37(8):4319-4327 ]

Selleck's DMH1 Has Been Cited by 63 Publications

Human skeletal development and regeneration are shaped by functional diversity of stem cells across skeletal sites [ Cell Stem Cell, 2025, S1934-5909(25)00081-5] PubMed: 40118065
Single-cell and spatial transcriptomics implicate a prognostic function of tertiary lymphoid structures in gastric cancer [ Nat Commun, 2025, 16(1):10435] PubMed: 41290589
Disruption of PRC1 components RING1A and RING1B promotes angiogenesis via relieving BMP4 repression [ J Adv Res, 2025, S2090-1232(25)00553-3] PubMed: 40684938
LXR agonist rescues synaptic dysfunction and degeneration in SPG3A patient-specific iPSC-derived neurons [ Acta Neuropathol Commun, 2025, 13(1):236] PubMed: 41250225
Machine learning-based proteomics profiling of ALS identifies downregulation of RPS29 that maintains protein homeostasis and STMN2 level [ Commun Biol, 2025, 8(1):1177] PubMed: 40775435
Culture conditions differentially regulate the inflammatory niche and cellular phenotype of tracheobronchial basal stem cells [ Am J Physiol Lung Cell Mol Physiol, 2025, 328(4):L538-L553] PubMed: 39982813
Allosteric Inhibition of P-Glycoprotein-Mediated Efflux by DMH1 [ Biomedicines, 2025, 13(8)1798] PubMed: 40868055
Dual RNA sequencing of a co-culture model of Pseudomonas aeruginosa and human 2D upper airway organoids [ Sci Rep, 2025, 15(1):2222] PubMed: 39824906
Electroacupuncture Preconditioning Ameliorates the Ischemic Microenvironment to Improve Long-Term Potentiation in Chronic Cerebral Hypoperfusion Rats With MGE Neural Progenitor Transplantation [ Neural Plast, 2025, 2025:9933756] PubMed: 40969839
Fungal melanin suppresses airway epithelial chemokine secretion through blockade of calcium fluxing [ Nat Commun, 2024, 15(1):5817] PubMed: 38987270

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.